B
Bjørn Møller
Researcher at Norwegian Institute of Public Health
Publications - 82
Citations - 5470
Bjørn Møller is an academic researcher from Norwegian Institute of Public Health. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 30, co-authored 65 publications receiving 4731 citations.
Papers
More filters
Journal ArticleDOI
Human Papillomavirus Infection as a Risk Factor for Squamous-Cell Carcinoma of the Head and Neck
Jon Mork,Anne Kveim Lie,Eystein Glattre,G. Hallmans,Egil Jellum,Pentti Koskela,Bjørn Møller,Eero Pukkala,John T. Schiller,Linda Youngman,Matti Lehtinen,Joakim Dillner,Joakim Dillner +12 more
TL;DR: HPV-16 infection may be a risk factor for squamous-cell carcinoma of the head and neck in subjects who were seropositive for HPV-16, and no increased risk was observed for other HPV types.
Journal ArticleDOI
Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness
Inger Kristin Larsen,Milada Cvancarova Småstuen,Tom Børge Johannesen,Frøydis Langmark,Donald Maxwell Parkin,Freddie Bray,Bjørn Møller +6 more
TL;DR: The routines in place at the CRN yields comparable data that can be considered reasonably accurate, close-to-complete and timely, thereby justifying the policy of the reporting of annual incidence one year after the year of diagnosis.
Journal ArticleDOI
A national strategic change in treatment policy for rectal cancer--implementation of total mesorectal excision as routine treatment in Norway. A national audit.
A. Wibe,Bjørn Møller,Jarle Norstein,Erik Carlsen,Johan N. Wiig,Richard J. Heald,F. Langmark,Helge E. Myrvold,Odd Søreide +8 more
TL;DR: A refinement of the surgical resection technique for rectal cancer can be achieved on a national level, the technique of total mesorectal excision can be widely distributed, and surgery alone can give good results.
Journal Article
Prediction of cancer incidence in the Nordic countries up to the year 2020.
Bjørn Møller,Harald Fekjaer,Timo Hakulinen,Laufey Tryggvadottir,Hans H. Storm,Mats Talbäck,Tor Haldorsen +6 more
Journal ArticleDOI
The past, present, and future of cancer incidence in the United States: 1975 through 2020
TL;DR: The overall age‐standardized cancer incidence rate continues to decline whereas the number of cases diagnosed each year increases, which can help to anticipate future resource needs, evaluate primary prevention strategies, and inform research.